Cigna/Express Scripts cleared: The Tipline for 18 September 2018

One of the two pending vertical healthcare mergers is cleared to go ahead, after the Department of Justice’s antitrust division allowed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act to expire for insurer Cigna’s $52 billion merger with pharmacy benefit manager Express Scripts. We also have stories on the latest in the Androgel litigation and two new additions at the Antitrust Division.

Get unlimited access to all Global Competition Review content